What is Bella & Duke?
Bella & Duke operates at the intersection of the pet care industry and the subscription economy, specializing in the delivery of raw, natural pet food. By offering a curated selection of fresh ingredients and personalized nutrition plans for dogs and cats, the company addresses the rising consumer preference for transparency and health-conscious pet maintenance. Beyond its core food offerings, the firm has integrated value-added services such as 24/7 video veterinary consultations and a dedicated community platform, effectively creating a comprehensive ecosystem for pet owners. This holistic approach to pet wellness differentiates Bella & Duke from traditional retail competitors, allowing for higher customer retention and recurring revenue streams.
How much funding has Bella & Duke raised?
Bella & Duke has raised a total of $14.3M across 2 funding rounds:
Other Financing Round
$4.4M
Other Financing Round
$9.9M
Other Financing Round (2020): $4.4M, investors not publicly disclosed
Other Financing Round (2021): $9.9M led by BGF and Mobeus Equity Partners
Key Investors in Bella & Duke
BGF
BGF is a leading UK-based investment firm that provides long-term capital to small and mid-sized businesses, supporting growth across diverse sectors through a patient, minority-stake approach.
Mobeus Equity Partners
Mobeus Equity Partners is a prominent private equity firm specializing in management buyouts and growth capital for UK SMEs, focusing on businesses with strong management teams and significant expansion potential.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Bella & Duke?
With the recent influx of capital, Bella & Duke is poised to transition into a more mature phase of enterprise-level growth. Strategic priorities likely include expanding their logistics network to support a wider geographic footprint and investing in data-driven personalization to further refine their nutrition plans. As the company scales, the focus will shift toward optimizing supply chain efficiencies and potentially diversifying their product portfolio to include advanced supplements or specialized health services. The backing from seasoned institutional investors provides the necessary runway to solidify their leadership position in the UK market while exploring potential international expansion opportunities in the evolving pet health landscape.
See full Bella & Duke company page
